In the IMvigor210 BLCA cohort, although the response to immunotherapy was better in the low MMP14 expression group compared to the high expression group, this difference did not reach statistical significance ( p = 0.11) (Fig. 5 L).
← all excerpts
Basement membrane-related MMP14 predicts poor prognosis and response to immunotherapy in bladder cancer.
1
0.1100
0.1100